RNF43 and signet ring cell carcinoma: In fact, the signet-ring cell carcinoma, a rare subtype of CRC with a high (34.5%) RNF43 mutation rate, actually showed significantly inhibited Wnt/β-catenin signaling than those without RNF43 mutations (50).